1. Drug introduction thermotherapy instrument for the Drug Administration approved the production of formal medical equipment, registration number: Hebei Food and Drug Administration Measures (quasi) word 2013 No. 2260038, the most commonly used is the GZ-IIIC-type drug introduction thermotherapy instrument, is the use of low-frequency modulation of intermediate frequency pulsed current, the drug guide, intermediate-frequency electricity and drug introduction combined together to achieve the therapeutic effect of the disease, clinically verified It has been proved to have definite curative effect. The operation of this therapeutic instrument is simple and easy to understand, safe to use, easy to carry, especially suitable for clinics and family use. The product consists of body, electronic circuit, power supply, electrode, electric heating pad and so on.
2. Technical parameters
Power supply: rated voltage 220v rated power 50Hz
Use of ambient temperature: 5 ℃ -40 ℃ Relative humidity: ≤ 85%
Atmospheric pressure: 860hpa-1060hpa
Output parameters are in the case of the load for the measurement of the value of the 1K case, when the load impedance decreases. When the load impedance decreases, the pulse amplitude decreases, the pulse frequency and pulse width remain unchanged.
Pulse Frequency: Main Frequency: 4Hz±20%, Carrier Frequency: 5000HZ±500hz
Pulse Amplitude: Minimum to Maximum Continuously Adjustable, Minimum Value Not Exceeding 2% of Maximum Value, Maximum Value 32vp-p-38vp-p
Input Power: ≤30va, Electrode Size: 96mm*58mm
Electric heating pad size: 150mm*150mm
Electric heating pad temperature: 37℃-55℃
Timing: 20min
The fuse: power insurance 0.5a, electric heating insurance 1a
Safety Classification "Ⅱ class BF type application part
Use term: Normal operation for 8 years
Security Classification "Ⅱ class BF type application part
Use term: Normal operation for 8 years